MX2009001116A - Metodos y preparaciones farmaceuticas para contribuir al tratamiento de la neuropatia inducida por la quimioterapia. - Google Patents

Metodos y preparaciones farmaceuticas para contribuir al tratamiento de la neuropatia inducida por la quimioterapia.

Info

Publication number
MX2009001116A
MX2009001116A MX2009001116A MX2009001116A MX2009001116A MX 2009001116 A MX2009001116 A MX 2009001116A MX 2009001116 A MX2009001116 A MX 2009001116A MX 2009001116 A MX2009001116 A MX 2009001116A MX 2009001116 A MX2009001116 A MX 2009001116A
Authority
MX
Mexico
Prior art keywords
leteprinim
cisplatin
pharmaceutical preparation
administration
treatment
Prior art date
Application number
MX2009001116A
Other languages
English (en)
Spanish (es)
Inventor
Luigi Lenaz
Guru Reddy
Doria Mirejovsky
Original Assignee
Spectrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc filed Critical Spectrum Pharmaceuticals Inc
Publication of MX2009001116A publication Critical patent/MX2009001116A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2009001116A 2006-08-01 2007-08-01 Metodos y preparaciones farmaceuticas para contribuir al tratamiento de la neuropatia inducida por la quimioterapia. MX2009001116A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82108206P 2006-08-01 2006-08-01
PCT/US2007/075008 WO2008017000A2 (en) 2006-08-01 2007-08-01 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy

Publications (1)

Publication Number Publication Date
MX2009001116A true MX2009001116A (es) 2009-02-10

Family

ID=38744846

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009001116A MX2009001116A (es) 2006-08-01 2007-08-01 Metodos y preparaciones farmaceuticas para contribuir al tratamiento de la neuropatia inducida por la quimioterapia.

Country Status (12)

Country Link
EP (1) EP2046335A2 (enExample)
JP (1) JP2009545619A (enExample)
KR (1) KR20090047501A (enExample)
CN (1) CN101657199A (enExample)
BR (1) BRPI0715504A2 (enExample)
CA (1) CA2659477A1 (enExample)
IL (1) IL196824A0 (enExample)
MX (1) MX2009001116A (enExample)
NO (1) NO20090279L (enExample)
RU (1) RU2009107123A (enExample)
WO (1) WO2008017000A2 (enExample)
ZA (1) ZA200900728B (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004448A2 (en) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions

Also Published As

Publication number Publication date
BRPI0715504A2 (pt) 2014-05-06
EP2046335A2 (en) 2009-04-15
IL196824A0 (en) 2009-11-18
RU2009107123A (ru) 2010-09-10
CA2659477A1 (en) 2008-02-07
KR20090047501A (ko) 2009-05-12
WO2008017000A3 (en) 2008-03-20
WO2008017000A8 (en) 2009-04-30
ZA200900728B (en) 2010-03-31
CN101657199A (zh) 2010-02-24
NO20090279L (no) 2009-02-26
JP2009545619A (ja) 2009-12-24
WO2008017000A2 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
Xiao et al. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat
US20090137619A1 (en) Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
WO2007092414A2 (en) Use of phosphatases to treat tumors overexpressing n-cor
US20090018142A9 (en) Use of phosphatases to treat tumors overexpressing N-CoR
US12310933B2 (en) Treatment of demyelinating disorders
US12201608B2 (en) Methods for treating Parkinson's disease by administering resiniferatoxin
EP3113775A1 (en) Use of eribulin and mtor inhibitors as combination therapy for the treatment of cancer
KR20240013092A (ko) 화학요법-유도된 말초 신경병증과 관련된 통증 치료
KR20050115273A (ko) 통증 치료용 화합물
WO2022052017A1 (en) Pharmaceutical compositions and uses thereof in treating muscle atrophy
Chiorazzi et al. Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models
DK3099307T3 (en) Use of cladribine for the treatment of neuromyelitis optica
Puniak et al. Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma
CN111836622A (zh) 线粒体-氯尼达明、组合物和使用方法
JP2009534360A (ja) アルファ−ケトグルタレートを含む組成物およびその筋性能を調節するための使用
AU2011285703B2 (en) Methods and pharmaceutical compositions for treating adverse or deleterious sequellae of traumatic brain injury
WO2008017000A2 (en) Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy
Salzman Neural monitoring: the prevention of intraoperative injury
CA3238640A1 (en) Method for treating cancer with acylfulvene and radiation
JP7847357B2 (ja) ミトコンドリアを標的とするイソケタール／イソレブグランジンスカベンジャー
KR20070030331A (ko) 신경 친화성 타크로리무스 유사체
Popović et al. Effects of metformin and its combinations with other repurposed drugs on fibrosarcoma in hamsters
RU2838908C2 (ru) Соединения инозитолфосфата для применения для увеличения тканевой перфузии
US11446264B2 (en) Memory manipulation via modification of protein kinase C zeta activity
CN121419776A (zh) 治疗多发性硬化症的伊博格碱

Legal Events

Date Code Title Description
FA Abandonment or withdrawal